Abstract
The effects of two 5-lipoxygenase (5LO) inhibitors, ZD2138 or Zileuton, on acute, inflammatory responses to aerosolizedAscaris suum (Ag) were determined in atopicMacaca fascicularis monkeys. Monkeys (n=6 each group) were dosed with vehicle, 3 or 10 mg/kg ZD2138, or 30 mg/kg Zileuton (p.o.). Both ZD2138 or Zileuton significantly inhibited ex vivo LTB4 production in Ca2+ ionophore-stimulated whole blood from these same monkeys (n=6 each group) by 45.5% (3 mg/kg ZD2138), 82.5% (10 mg/kg ZD2138) and 84.3% (30 mg/kg Zileuton). ZD2138 (10 mg/kg) reduced bronchoalveolar lavage (BAL) LTE4 levels (65.1% inhibition), BAL neutrophils (88.9% inhibition), and IL-6 (54.0% inhibition) 4h post Ag. Zileuton inhibited these responses and also reduced BAL levels of IL-8 (73.4% inhibition). A second study was performed to evaluate the effects of ZD2138 on chronic Ag-induced responses. Treatment with ZD2138 did not prevent pulmonary inflammation or the development of airway hyperresponsiveness (AHR). Based upon these results, 5LO inhibition significantly reduced ex vivo LTB4 and in vivo LTE4 production as well as several acute inflammatory responses to Ag in the lung. However, ZD2138 did not inhibit more chronic responses following multiple Ag exposure.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Rouzer CA, Matsumoto T, Samuelsson B. Single protein from human leukocytes possesses 5-lipoxygenase and leukotriene A4 synthase activities. Proc Natl Acad Sci USA 1986;83:857–61.
Ford-Hutchinson AW, Bray MA, Doig MU, Shipley ME, Smith JH. Leukotriene B4, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes. Nature 1981;286:264–5.
Dahlen JE, Hedquist B, Hammarstrom, Samuelsson B. Leukotrienes are potent constrictors of human bronchi. Nature 1980;288:484–6.
McMillen RM, Spruce KE, Crawley GC, Walker ERH, Foster SJ. Pre-clinical pharmacology of ICI D2138, a potent orally-active non-redox inhibitor of 5-lipoxygenase. Br J Pharmacol 1992;107:1042–7.
Turner CR, Smith WB, Andresen CJ, Swindell AC, Watson JW. Leukotriene D4 receptor antagonism reduces airway hyperresponsiveness in monkeys. Pulmon Pharmacol 1994;7:49–58.
Gundel RH, Gerritsen ME, Gleich GJ, Wegner CD. Repeated antigen inhalation results in a prolonged airway eosinophilia and airway hyperresponsiveness in primates. J Appl Physiol 1990;68(2):779–86.
Gundel RH, Wegner CD, Letts LG. Antigen-induced acute and late-phase responses in primates. Am Rev Respir Dis 1992;146:369–73.
Wegner CD, Jackson AC, Berry JD, Gillespie JR. Dynamic respiratory mechanics in monkeys measured by forced oscillations. Respir Physiol 1984;55:47–61.
Brach MA, de Vos S, Arnold C, Grub H-J, Mertelsmann R, Herrmann F. Leukotriene B4 transcriptionally activates interleukin-6 expression involving NK-xB and NF-IL-6. Eur J Immunol 1992;22:2705–11.
Bradding P, Feather IH, Wilson S, Bardin PG, Heusser CH, Holgate ST, et al. Immunolocalization of cytokines in the nasal mucosa of normal and perennial rhinitic subjects. J Immunol 1993;151:3853–65.
Lutter R, Out TA, Jansen HM. Superinduction and super-production of interleukin-6 by lung epithelial cells. Am Rev Respir Dis 1993;147:A19.
Atluru D, Gudapaty S, O'Donnell MP, Woloschak GE. Inhibition of human mononuclear cell proliferation, interleukin synthesis, mRNA for IL-2, IL-6 and leukotriene B4 synthesis by a lipoxygenase inhibitor. J Leukocyte Biol 1993;54:269–74.
Broide DH, Lotz M, Cuomo AJ, Coburn DA, Federman EC, Wasserman SI. Cytokines in symptomatic asthmatic airways. J Allergy Clin Immunol 1992;89:958–67
Osborn RR, Hay DWP, Wasserman MA, Torphy TJ. SKF 104353, a selective leukotriene receptor antagonist, inhibits leukotriene D4 — and antigen-induced bronchoconstriction in cynomolgus monkeys. Pulmon Pharmacol 1992;5:153–7.
Sim TC, Grant JA, Hilsmeier KA, Fukuda Y, Alam R. Proinflammatory cytokines in nasal secretions of allergic subjects after antigen challenge. Am J Resp Crit Care Med 1994;149:339–44.
Gundel RH, Torcellini CA, Clarke CC, Desai S, Lazer ES, Wegner CD. The effects of a 5-lipoxygenase inhibitor on antigen-induced mediator release, late phase bronchoconstriction and cellular infiltrates in primates. Adv Prostaglandin, Thromboxane Leukotriene Res 1990;21:457–60.
Boulet LP, Cartier A, Thomson NC, Roberts RS, Dolovich J, Hargreave FE. Asthma and increases in nonallergic bronchial responsiveness from seasonal pollen exposure. J Allergy Clin Immunol 1983;71:399–403.
Wegner CD, Gundel RH, Abraham WM, Schulman ES, Kontny MJ, Lazer ES, et al. The role of 5-lipoxygenase products in preclinical models of asthma. J Allergy Clin Immunol 1993;91:917–29.
Diamant Z, Timmers MC, van der Keen H, Friedman BS, De Smet M, Tanaka W, et al. The effect of MK-591, a potent oral leukotriene biosynthesis inhibitor, on allergen-induced airway responses in asthmatic subjects. Am Rev Respir Dis 1993; 147:A446.
Hui KP, Taylor IK, Taylor GW, Robin P, Kesterson J, Barnes NC, et al. Effect of a 5-lipoxygenase inhibitor on leukotriene generation and airway responses after allergen challenge in asthmatic patients. Thorax 1991;46:184–9.
Turner CR, Breslow R, Conklyn MJ, Andresen CJ, Patterson DK, Lopez-Anaya, et al. The in vitro and in vivo effects of the LTB4 antagonist, CP-105,696, in a primate model of asthma. In press.
Resnick MB, Weller PF. Mechanisms of eosinophil recruitment. Am J Respir Cell Mol Biol 1993;8:349–55.
Israel E, Drazen J, Pearlman H, Conn J, Rubin P. A double-blinded multicenter study of zileuton, a potent 5-lipoxygenase (5-LO) inhibitor versus placebo in the treatment of spontaneous asthma in adults. J Allergy Clin Immunol 1992;89:236.
Turner CR, Andresen CJ, Smith WB, Watson JW. 1994. Effects of rolipram on responses to acute and chronic antigen exposure in monkeys. Am J Respir Crit Care Med. 149:1154–9.
Author information
Authors and Affiliations
Additional information
accepted by M.J. Parnham
Rights and permissions
About this article
Cite this article
Turner, C.R., Smith, W.B., Andresen, C.J. et al. The effect of 5-lipoxygenase inhibition on Ascaris antigen (Ag)-induced responses in atopic monkeys. Inflamm Res 45, 42–49 (1996). https://doi.org/10.1007/BF02263504
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02263504